Regarding the combination of gemcitabine and paclitaxel, paclitaxel has been shown to increase the concentration of gemcitabine in the tumor tissue by inhibition of the enzyme cytidine deaminase leading to reduced gemcitabine elimination [42]. This evidence concerns the gene CDA and neoplasm.